Facebook
Twitter
Telegram
Report an ErrorArcus Biosciences Financial Statements 2011-2024 | RCUS
Annual Financial Statements Arcus Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.21 B | 1.31 B | 2.58 B | 1.93 B | 399 M | 329 M | - | - | - | - | - | - | - |
Shares |
74 M | 72 M | 69.3 M | 54.8 M | 43.8 M | 34.6 M | - | - | - | - | - | - | - |
Historical Prices |
16.4 | 18.2 | 37.2 | 35.3 | 15.2 | 11.8 | - | - | - | - | - | - | - |
Net Income |
-307 M | -267 M | 53 M | -123 M | -84.7 M | -49.6 M | -53.1 M | -18 M | - | - | - | - | - |
Revenue |
117 M | 112 M | 383 M | 78 M | 15 M | 8.35 M | 1.41 M | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-340 M | -280 M | 54 M | -124 M | -88.7 M | -54.9 M | -53.4 M | -18.2 M | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-332 M | -274 M | 58 M | -121 M | -85.1 M | -51.2 M | -50.8 M | -16.9 M | - | - | - | - | - |
Operating Expenses |
457 M | 392 M | 329 M | 202 M | 104 M | 63.2 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
117 M | 104 M | 72 M | 43 M | 25.2 M | 13.6 M | 7.64 M | 3.94 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Arcus Biosciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
86.2 M | 75.5 M | 74.6 M | 73.2 M | 73 M | 72.9 M | 72.2 M | 71.8 M | 71.2 M | 70.8 M | 70.1 M | 69.7 M | 67.1 M | 63.5 M | 62.6 M | 48.6 M | 44.3 M | 44.1 M | 43.9 M | 45.4 M | 44.5 M | 43.2 M | 44.5 M | 44.5 M | 11.6 M | 2.21 M | 3.99 M | 3.9 M | 3.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-4 M | - | -71 M | -75 M | -80 M | - | -65 M | -67 M | -68 M | - | -78 M | -76 M | -72.6 M | -51.9 M | 1.82 M | -45.1 M | -27.8 M | -16.6 M | -22.4 M | -28.1 M | -17.7 M | -12.3 M | -10.8 M | -13.5 M | -13 M | -13.2 M | -23.1 M | -9.55 M | -7.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
145 M | - | 32 M | 29 M | 25 M | - | 33 M | 27 M | 18 M | - | 9.46 M | 9.46 M | 9.46 M | 9.49 M | 64.5 M | 1.75 M | 1.75 M | 9.75 M | 1.75 M | 1.75 M | 1.75 M | 1.56 M | 4.29 M | 1.25 M | 1.25 M | 1.25 M | 163 K | -141 K | -70 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-16 M | - | -80 M | -83 M | -86 M | - | -70 M | -69 M | -67 M | - | -78.1 M | -76.1 M | -72.7 M | - | 1.55 M | -45.4 M | -28.4 M | - | -23.2 M | -29.2 M | -18.8 M | - | -12.1 M | -15.9 M | -13.3 M | - | -23.1 M | -9.66 M | -7.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-13 M | - | - | - | -84 M | - | -65.5 M | -69 M | -66 M | - | -75.6 M | -76.1 M | -71.9 M | - | 3.92 M | -43.7 M | -27.6 M | - | -22.4 M | -28.4 M | -17.8 M | - | -11.2 M | -15 M | -12.5 M | - | -22.4 M | -9.06 M | -6.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
161 M | - | 112 M | 112 M | 111 M | - | 103 M | 96 M | 85 M | - | 87.6 M | 85.6 M | 82.2 M | 61.5 M | 63 M | 47.1 M | 30.2 M | 27.3 M | 25 M | 30.9 M | 20.5 M | 15 M | 16.4 M | 17.1 M | 14.6 M | 14.6 M | 23.3 M | 9.66 M | 7.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
32 M | - | 30 M | 28 M | 30 M | - | 26 M | 26 M | 24 M | - | 16.3 M | 16.8 M | 15.8 M | - | 11.2 M | 11.4 M | 7.01 M | - | 7.76 M | 5.91 M | 4.97 M | - | 3.58 M | 3.45 M | 2.93 M | - | 1.86 M | 1.83 M | 1.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency